This content is machine translated COPD treatment Fewer exacerbations with mucolytics Mucolytics are included in several guidelines as a treatment option for patients with frequent exacerbations. According to GOLD, they can reduce exacerbations and marginally improve health status. However, evidence is…
View Post 4 min This content is machine translated Cystic fibrosis Even one mutated gene increases the risk In autosomal recessive diseases such as cystic fibrosis (CF), one is dealing with the inheritance of two mutated genes. Previously, CFTR* expression levels of 50% were thought to be sufficient…
View Post 2 min This content is machine translated SARS-CoV-2 Telemonitoring of respiratory therapy reduces risk of infection Innovative and digital devices for sleep and ventilation therapy enable efficient and clinically qualitative care for people with sleep-related breathing disorders, COPD and other chronic diseases. Telemonitoring offers an alternative…
View Post 3 min This content is machine translated COPD - Acute exacerbations Less antibiotics through CRP testing When acute exacerbations occur in COPD patients, antibiotics are often the first-line treatment. However, their use is always associated with the risk of potentially unfavorable effects. Researchers have investigated the…
View Post 3 min This content is machine translated Guideline Intensive Care Medicine Preoxygenation with bag ventilation – an absolutely sensible measure In 2019, the new S1 guideline “Prehospital airway management” was published. Preoxygenation and mask ventilation are of central importance. Two studies have provided clear answers to this.
View Post 15 min This content is machine translated Chronic Thromboembolic Pulmonary Hypertension Diagnostics and therapy of CTEPH Chronic thromboembolic pulmonary hypertension (CTEPH) is a subtype of pulmonary hypertension (PH). The diagnosis is overall very rare, although CTEPH is also often unrecognized and thus underdiagnosed, and therefore the…
View Post 2 min This content is machine translated Severe COVID-19 courses Which lung patients need special protection Most people who become infected with the new SARS-CoV-2 coronavirus do not become severely ill. However, patients with chronic respiratory and pulmonary diseases are particularly confused. The German Society for…
View Post 2 min This content is machine translated New therapy study Ruxolitinib against strong inflammatory response Ruxolitinib has been used to treat myeloid diseases of the bone marrow. Experts from the Department of Internal Medicine III at Ulm University Hospital (Germany) are now investigating how corona…
View Post 1 min This content is machine translated CORIMUNO-TOCI Study Significant COVID-19 improvement with tocilizumab. In patients with COVID-19 pneumonia, an immune-mediated “cytokine storm” is thought to lead to acute respiratory failure and death. The CORIMUNO-19 platform was rapidly developed and established to evaluate the…
View Post 1 min This content is machine translated 2019-nCoV Over 60 approved clinical trials in Switzerland A list of clinical trials currently conducted in Swiss hospitals is available on the website of the Swiss Association of Research Ethics Committees.
View Post 9 min This content is machine translated Peripheral cryobiopsy Invasive diagnosis of diffuse parenchymatous lung disease. Histologic diagnosis is sometimes necessary for the differential diagnosis of idiopathic pulmonary fibrosis (IPF) as one of the most common forms of idiopathic interstitial pneumonitis. In the event that invasive…
